Figure 7.
Outcome according to evaluated apoptotic biomarkers. (A-B) Association between whole biopsy and intrafollicular CASP3 expression and TFS (cutoffs, AF = 0.1423 and AF = 0.3627, respectively). (C-D) Association between whole biopsy and intrafollicular MCL1 expression and TFS (cutoffs, AF = 0.1133 and AF = 0.0264, respectively). (E-F) Association between whole biopsy and intrafollicular BAX expression and TFS (cutoffs, AF = 0.6221 and AF = 0.882, respectively). (G-H) Association between whole biopsy and intrafollicular BCL-xL expression and TFS (cutoffs, AF = 0.0007 and AF = 0.0007, respectively). (I-J) Association between whole biopsy and intrafollicular BCL-rambo expression and TFS (cutoffs, AF = 0.022 and AF = 0.0182, respectively). (K) Association between TFS and high whole tumor coexpression of 0 to 2, 3, and 4 to 5 of the analyzed markers. (L) Association between TFS and high intrafollicular coexpression of 0 to 2, 3, and 4 to 5 of the analyzed markers.

Outcome according to evaluated apoptotic biomarkers. (A-B) Association between whole biopsy and intrafollicular CASP3 expression and TFS (cutoffs, AF = 0.1423 and AF = 0.3627, respectively). (C-D) Association between whole biopsy and intrafollicular MCL1 expression and TFS (cutoffs, AF = 0.1133 and AF = 0.0264, respectively). (E-F) Association between whole biopsy and intrafollicular BAX expression and TFS (cutoffs, AF = 0.6221 and AF = 0.882, respectively). (G-H) Association between whole biopsy and intrafollicular BCL-xL expression and TFS (cutoffs, AF = 0.0007 and AF = 0.0007, respectively). (I-J) Association between whole biopsy and intrafollicular BCL-rambo expression and TFS (cutoffs, AF = 0.022 and AF = 0.0182, respectively). (K) Association between TFS and high whole tumor coexpression of 0 to 2, 3, and 4 to 5 of the analyzed markers. (L) Association between TFS and high intrafollicular coexpression of 0 to 2, 3, and 4 to 5 of the analyzed markers.

Close Modal

or Create an Account

Close Modal
Close Modal